{
    "clinical_study": {
        "@rank": "33567", 
        "acronym": "NAPA", 
        "arm_group": [
            {
                "arm_group_label": "Immediate Nexplanon Insertion", 
                "arm_group_type": "Experimental", 
                "description": "An etonogestrel rod will be placed within 15 minutes following the abortion procedure."
            }, 
            {
                "arm_group_label": "Post-op Nexplanon Insertion", 
                "arm_group_type": "Active Comparator", 
                "description": "Participants in the \"delayed\" placement group will be asked to return to Magee-Womens Hospital for a post-abortion visit 2-4 weeks following the procedure. Participants in the delayed group will be offered a method of contraception to use in the interim between their procedure and their insertion appointment.  At this time an etonogestrel rod will be placed in her arm using standard procedure."
            }
        ], 
        "brief_summary": {
            "textblock": "Women who receive Nexplanon immediately post abortion will be significantly more likely to\n      be using the device 6 months after the procedure than those assigned to receive the device\n      2-4 weeks after the procedure."
        }, 
        "brief_title": "Nexplanon Application Post-Abortion", 
        "completion_date": {
            "#text": "August 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Contraception", 
            "Abortion, Therapeutic"
        ], 
        "detailed_description": {
            "textblock": "Women will be contacted 6 months after their abortion to ask about contraception use and\n      side effects."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  18 years of age and older,\n\n          -  an intrauterine pregnancy > 14 weeks and <23 6/7 weeks gestation and desire\n             termination of pregnancy\n\n          -  desire a Nexplanon for contraception\n\n          -  able to give informed consent in English\n\n          -  no contraindications to Nexplanon (based on U.S. CDC Medical Eligibility Criteria for\n             Contraception) or D&E\n\n        Exclusion Criteria:\n\n          -  unable to give informed consent\n\n          -  have any of the following medical conditions: active venous thromboembolism, known or\n             suspected sex-steroid sensitive malignancies, current hepatic disease with abnormal\n             liver function tests, undiagnosed vaginal bleeding, hypersensitivity to any of the\n             ingredients in Nexplanon.\n\n          -  non-surgical management of pregnancy\n\n          -  prior participation in this study\n\n          -  breast cancer or a history of breast cancer"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 14, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02037919", 
            "org_study_id": "IIS#50302: Women's Health MISP"
        }, 
        "intervention": [
            {
                "arm_group_label": "Immediate Nexplanon Insertion", 
                "description": "Patient will have a Nexplanon inserted within 15 minutes of her abortion", 
                "intervention_name": "Immediate Nexplanon Insertion", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Post-op Nexplanon Insertion", 
                "description": "Place Nexplanon at post operative visit  rather than at surgery", 
                "intervention_name": "Post-op Nexplanon Insertion", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "3-keto-desogestrel"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 14, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Pittsburgh", 
                    "country": "United States", 
                    "state": "Pennsylvania", 
                    "zip": "15213"
                }, 
                "name": "University of Pittsburgh"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Immediate vs. Delayed Insertion of Nexplanon After Termination of Pregnancy Over 14-weeks Gestation (NAPA)", 
        "overall_contact": {
            "email": "gilmoremn@upmc.edu", 
            "last_name": "Melissa Gilmore Fann, MPH", 
            "phone": "412-641-5533"
        }, 
        "overall_contact_backup": {
            "email": "kristenkamp@gmail.com", 
            "last_name": "Kristen Kamp, MPH", 
            "phone": "412-760-0243"
        }, 
        "overall_official": {
            "affiliation": "University of Pittsburgh", 
            "last_name": "Miriam Cremer, MD,MPH", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Current use of Nexplanon, confirmed via phone by participant palpation, at 6 months post-insertion.", 
            "measure": "Nexplanon use", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02037919"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Pittsburgh", 
            "investigator_full_name": "Miriam Cremer", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Occurrence of a pregnancy within 6 months after second-trimester abortion.", 
                "measure": "Repeat pregnancy", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "Qualitative and quantitative self-reports of common side-effects of Nexplanon use.", 
                "measure": "Side-effects of Nexplanon use", 
                "safety_issue": "No", 
                "time_frame": "6 mo."
            }, 
            {
                "description": "Satisfaction with contraceptive method, as assessed by a Satisfaction Questionnaire, at 6 months post-abortion.", 
                "measure": "Contraceptive method satisfaction", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }
        ], 
        "source": "University of Pittsburgh", 
        "sponsors": {
            "collaborator": {
                "agency": "Merck Sharp & Dohme Corp.", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "University of Pittsburgh", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}